Glaxosmithkline Pharmaceuticals Ltd. | GLAXO | NSE - Pharmaceuticals


Performance  |  Valuation  |  Growth  |  Insiders  |  Summary

Financial Summary Report of Glaxosmithkline Pharmaceuticals Ltd.



GLAXO
Glaxosmithkline Pharmaceuticals Ltd.

Rs. 1482.05
27-Oct-2021

5 Yr Performance

1 Yr Performance

Valuation




Analysis




Quarterly Revenue, Net Income and Adjusted Share Price




Peer Comparison


AstraZenca Pharma India Ltd.

Aurobindo Pharma Ltd.

Biocon Ltd.

Cadila Healthcare Ltd.

Cipla Ltd.

RPG Life Sciences Limited

Divis Laboratories Ltd.

Dr. Reddy's Laboratories Ltd.

FDC Ltd.

Fresenius Kabi Oncology Ltd.